Big Gain For Oncolytics Biotech Inc.
Mon, Dec 30, 2019 at 05:30 PM
Oncolytics Biotech Inc. (ONCY:NASDAQ) shot up at $3.87, representing a gain of 36.3%. On Fri 27 Dec 19, ONCY:NASDAQ hit a New 2-Week High of $2.84. The stock appeared on our News Catalysts scanner on Thu 12 Dec 19 at 07:58 AM in the 'BIOTECH' category. From Fri 06 Dec 19, the stock recorded 50.00% Up Days and 46.67% Green Days
About Oncolytics Biotech Inc. (ONCY:NASDAQ)
Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
Top 10 Gainers:
- Savara Inc. (SVRA:NASDAQ), 183.82%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 61.28%
- Sol-Gel Technologies Ltd. (SLGL:NASDAQ), 58.18%
- NIO Inc. (NIO:NYSE), 53.72%
- Ocugen, Inc. (OCGN:NASDAQ), 44.75%
- Ra Medical Systems, Inc. (RMED:NYSE), 38.52%
- ERYTECH Pharma S.A. (ERYP:NASDAQ), 37.94%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 36.27%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 32.28%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 31.04%